| Autor: |
Georgiadis, P, Liampa, I, Hebels, DG, Krauskopf, J, Chatziioannou, A, Valavanis, I, de Kok, TMCM, Kleinjans, JCS, Bergdahl, IA, Melin, B, Spaeth, F, Palli, D, Vermeulen, RCH, Vlaanderen, J, Chadeau-Hyam, M, Vineis, P, Kyrtopoulos, SA, EnviroGenomarkers consortium |
| Jazyk: |
angličtina |
| Rok vydání: |
2017 |
| Předmět: |
|
| ISSN: |
1471-2164 |
| Popis: |
Background B-cell chronic lymphocytic leukemia (CLL) is a common type of adult leukemia. It often follows an indolent course and is preceded by monoclonal B-cell lymphocytosis, an asymptomatic condition, however it is not known what causes subjects with this condition to progress to CLL. Hence the discovery of prediagnostic markers has the potential to improve the identification of subjects likely to develop CLL and may also provide insights into the pathogenesis of the disease of potential clinical relevance. Results We employed peripheral blood buffy coats of 347 apparently healthy subjects, of whom 28 were diagnosed with CLL 2.0–15.7 years after enrollment, to derive for the first time genome-wide DNA methylation, as well as gene and miRNA expression, profiles associated with the risk of future disease. After adjustment for white blood cell composition, we identified 722 differentially methylated CpG sites and 15 differentially expressed genes (Bonferroni-corrected p < 0.05) as well as 2 miRNAs (FDR < 0.05) which were associated with the risk of future CLL. The majority of these signals have also been observed in clinical CLL, suggesting the presence in prediagnostic blood of CLL-like cells. Future CLL cases who, at enrollment, had a relatively low B-cell fraction ( |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink